Auditor’s Report 2015 of Central Pharmaceuticals Limited

It is a broadly described auditor’s report of Central Pharmaceuticals Limited in the year of 2015. During the year under report, The Company’s Cost of Goods Sold Taka. 336,527,457 million. Gross Profit/(Loss) Taka. 324,265,957 million. Operating Income Taka. 240,260,878 million. Net Profit/(Loss) after Tax for the year Taka. 143,424,235 million. The shares of the Company are listed with both the Dhaka and Chittagong Stock Exchange and quoted at Tk. 27.80 per share and Tk. 27.80 per share in the Dhaka and Chittagong Stock Exchange respectively on 30 June 2015.

The board of the directors of the company in their meeting held on 28th October 2015 has proposed @15% stock dividend for the year ended 30 June 2015. The dividend is subject to approval by the shareholders at the forthcoming Annual General Meeting (AGM) of the company.  These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.

More Annual Report of Central Pharmaceuticals Limited:

  1. Annual Report 2014 of Central Pharmaceuticals Limited
  2. Auditor’s Report 2015 of Central Pharmaceuticals Limited
  3. Annual Report 2016 of Central Pharmaceuticals Limited
  4. Annual Report 2017 of Central Pharmaceuticals Limited